Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial

Status

Not yet recruiting

NCT ID

NCT06949800

This study is focused on treatment of anal high-grade squamous intraepithelial lesions (HSIL) in persons with HIV (PWH), with the ultimate goal of applying the approach toward prevention of anal cancer in this population

Intervention

EXE-346 Probiotic, Placebo, Usual Care High Resolution Anoscopy (HRA)

Condition

HSIL, High Grade Squamous Intraepithelial Lesion, HPV-Related Squamous Cell Carcinoma, Anal HSIL

Investigators

Joel Palefsky, MD, Salim Abraham Barquet-Munoz, MD,MSc, PhD, Ana Patricia Ortiz Martinez, MPH, MD

CT Research Area

Prevention

See list of participating sites